American Healthcare REIT Inc has a consensus price target of $16, established from looking at the 10 latest analyst ratings. The last 3 analyst ratings were released from Truist Securities, Truist Securities, and JMP Securities on April 3, 2024, March 25, 2024, and March 25, 2024. With an average price target of $16.33 between Truist Securities, Truist Securities, and JMP Securities, there's an implied 19.31% upside for American Healthcare REIT Inc from these 3 analyst ratings.
1calculated from analyst ratings published within the last 3 years
date | ticker | Buy Now | Company | Current price | Upside/Downside | Analyst Firm | Analyst & % Accurate | Price Target Change | Rating Change | Previous / Current Rating | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/03/2024 | AHR | Buy Now | American Healthcares | $13.69 | 16.87% | Truist Securities | Michael Lewis | $17 → $16 | Maintains | Buy | Get Alert |
03/25/2024 | AHR | Buy Now | American Healthcares | $13.69 | 24.18% | Truist Securities | Michael Lewis | → $17 | Reiterates | Buy → Buy | Get Alert |
03/25/2024 | AHR | Buy Now | American Healthcares | $13.69 | 16.87% | JMP Securities | Aaron Hecht | → $16 | Reiterates | Market Outperform → Market Outperform | Get Alert |
03/14/2024 | AHR | Buy Now | American Healthcares | $13.69 | 31.48% | Barclays | Anthony Powell | → $18 | Initiates | → Overweight | Get Alert |
03/04/2024 | AHR | Buy Now | American Healthcares | $13.69 | 9.57% | RBC Capital | Brian Cheng | → $15 | Initiates | → Outperform | Get Alert |
03/04/2024 | AHR | Buy Now | American Healthcares | $13.69 | 16.87% | JMP Securities | Aaron Hecht | → $16 | Initiates | → Market Outperform | Get Alert |
03/04/2024 | AHR | Buy Now | American Healthcares | $13.69 | 24.18% | Truist Securities | Michael Lewis | → $17 | Initiates | → Buy | Get Alert |
03/04/2024 | AHR | Buy Now | American Healthcares | $13.69 | 24.18% | Morgan Stanley | Ronald Kamdem | → $17 | Initiates | → Overweight | Get Alert |
03/04/2024 | AHR | Buy Now | American Healthcares | $13.69 | 2.26% | Citigroup | Michael Griffin | → $14 | Initiates | → Neutral | Get Alert |
03/04/2024 | AHR | Buy Now | American Healthcares | $13.69 | 16.87% | Keybanc | Austin Wurschmidt | → $16 | Initiates | → Overweight | Get Alert |
The latest price target for American Healthcares (NYSE: AHR) was reported by Truist Securities on April 3, 2024. The analyst firm set a price target for $16.00 expecting AHR to rise to within 12 months (a possible 16.87% upside). 10 analyst firms have reported ratings in the last year.
The latest analyst rating for American Healthcares (NYSE: AHR) was provided by Truist Securities, and American Healthcares maintained their buy rating.
There is no last upgrade for American Healthcares.
There is no last downgrade for American Healthcares.
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of American Healthcares, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for American Healthcares was filed on April 3, 2024 so you should expect the next rating to be made available sometime around April 3, 2025.
While ratings are subjective and will change, the latest American Healthcares (AHR) rating was a maintained with a price target of $17.00 to $16.00. The current price American Healthcares (AHR) is trading at is $13.69, which is out of the analyst’s predicted range.
Browse analyst ratings and price targets on all stocks.